Optimal timing of electrical cardioversion in patients with persistent atrial fibrillation

Franjo Naji1, Damijan Vokac, Vojko Kanic

  • 1Department of Cardiology and Angiology, University Medical Centre, Maribor, Slovenia. franjo.naji@yahoo.com

Insights

The duration of atrial fibrillation before electrical cardioversion is a key predictor of recurrence. Longer atrial fibrillation duration increases the risk of recurrence after successful cardioversion, while amiodarone may offer protection.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Atrial fibrillation recurrence post-cardioversion is a significant clinical challenge.
  • Limited data exist on the impact of atrial fibrillation duration prior to cardioversion on long-term outcomes.

Purpose of the Study:

  • To investigate the effect of atrial fibrillation duration on sinus rhythm maintenance after electrical cardioversion.
  • To identify predictors of atrial fibrillation recurrence in patients undergoing cardioversion.

Main Methods:

  • A cohort of 301 patients undergoing successful electrical cardioversion for persistent atrial fibrillation was analyzed.
  • Patients were followed for 2 years, with recurrence defined by electrocardiogram evidence of atrial fibrillation.

Main Results:

  • Atrial fibrillation recurred in 61.5% of patients within a mean follow-up of 377 days.
  • Multivariate analysis identified atrial fibrillation duration as the sole predictor of recurrence (OR 1.06).
  • A Cox model indicated that atrial fibrillation duration ≥10 months (OR 1.87) and amiodarone treatment (OR 0.55) predicted recurrence.

Conclusions:

  • The duration of atrial fibrillation before electrical cardioversion significantly predicts recurrence rates after rhythm restoration.
  • Further research is necessary to fully understand the implications of atrial fibrillation duration on maintaining sinus rhythm post-cardioversion.
Abstract

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...